Fahrni, Gregor
,
Scheller, Bruno
Coslovsky, Michael
Gilgen, Nicole
Farah, Ahmed
Ohlow, Marc-Alexander
Mangner, Norman
Weilenmann, Daniel
Wöhrle, Jochen
Cuculi, Florim
Leibundgut, Gregor
Möbius-Winkler, Sven
Zweiker, Robert
Twerenbold, Raphael
Kaiser, Christoph
Jeger, Raban http://orcid.org/0000-0003-1290-5491
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (12345)
Basel Cardiovascular Research Foundation
B. Braun Medical AG Switzerland (12345)
Article History
Received: 22 November 2019
Accepted: 16 January 2020
First Online: 29 January 2020
Compliance with ethical standards
:
: Dr. Jeger reports Grants from Swiss National Foundation, Grants from Basel Cardiovascular Research Foundation, Grants, personal fees and non-financial support from B. Braun Medical AG, Sempach, Switzerland during the conduct of the study; Dr. Mangner reports personal fees from Edwards Lifesciences, personal fees from Medtronic, personal fees from Biotronik, personal fees from Sanofi Genzyme, personal fees from Astra Zeneca and personal fees from Novartis outside the submitted work; Dr. Scheller reports other support from B.Braun, InnoRa GmbH and Charite University Hospital outside the submitted work; Dr. Twerenbold reports personal fees from Abbott, Roche, Siemens, Brahms, Singulex and Amgen, Grants from Swiss National Science Foundation, Swiss Heart Foundation, Swiss Society of Cardiology, University of Basel and Cardiovascular Research Foundation Basel outside the submitted work; all the other authors have nothing to disclose.